Shedding, Immunogenicity and Safety of Quadrivalent Live Intranasal Influenza Vaccine (QLAIV) in HIV-infected Children and Young Adults

Clinical trial NCT02474901 · COMPLETED

Trial details

NCT number: NCT02474901
Sponsor: University of Colorado, Denver
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Human Immunodeficiency Virus (HIV)

Start date: 2013-07-01
Primary completion: 2016-03-01
Enrollment: 101

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.